CNTN5 and glioma: Nonetheless, our findings are in-line with some of those reported in a cross-cancer case-control study (with blood collected at or after diagnosis) within the Uppsala-Umeå Comprehensive Cancer Consortium biobank; we replicated the reported association of GFAP with glioma and the associations of CNTN5, SLAMF7, MZB1, QPCT and TNFRSF13B with multiple myeloma31.